Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 08, 2018
Phase I trial of bortezomib (PS-341; NSC 681239) and "nonhybrid" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 25, 2014
A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 22, 2013
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies.
Journal: Cancer chemotherapy and pharmacology
Published: September 28, 2011
Showing 1-4 of 4
Last Updated: 09/26/2026